Preferred Label : pirenzepine;
MeSH definition : An antimuscarinic agent that inhibits gastric secretion at lower doses than are required
to affect gastrointestinal motility, salivary, central nervous system, cardiovascular,
ocular, and urinary function. It promotes the healing of duodenal ulcers and due to
its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence.
It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE.
It is generally well tolerated by patients.;
MeSH synonym : pyrenzepine; pirenzepin;
CISMeF synonym : ratiopharm brand of pirenzepine dihydrochloride; azupharma brand of pirenzepine dihydrochloride; dolorgiet brand of pirenzepine dihydrochloride; sagitta brand of pirenzepine dihydrochloride; ct-Arzneimittel brand of pirenzepine dihydrochloride; boehringer ingelheim brand of pirenzepine dihydrochloride;
MeSH hyponym : ulgescum; pirenzepin von ct; gastrozepin; gastrotsepin; pirenzepin-ratiopharm; pirenzepine dihydrochloride; piren-basan; L-S 519; ulcoprotect; LS-519; LS 519; LS519; Dihydrochloride, Pirenzepine; Piren Basan; Von Ct, Pirenzepin; Pirenzepin Ratiopharm;
MeSH CAS label : 6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-;
MeSH Related Number : 28797-61-7 (Pirenzepine); pirenzepine dihydrochloride; 10YM403FLS;
Registry Number MeSH : 28797-61-7;
Related CAS MeSH : 10YM403FLS (Pirenzepine dihydrochloride);
Wikipedia link : https://en.wikipedia.org/wiki/Pirenzepine;
Codes EINECS : 249-228-4;
Is substance : O;
UNII : 3G0285N20N;
InChIKey : RMHMFHUVIITRHF-UHFFFAOYSA-N;
Origin ID : D010890;
UMLS CUI : C0031978;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- LS 75 [MeSH Supplementary Concept]
- LS 822 [MeSH Supplementary Concept]
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An antimuscarinic agent that inhibits gastric secretion at lower doses than are required
to affect gastrointestinal motility, salivary, central nervous system, cardiovascular,
ocular, and urinary function. It promotes the healing of duodenal ulcers and due to
its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence.
It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE.
It is generally well tolerated by patients.